Iron Therapy

Ewa Jankowska, Marcin Drozd, Michał Tkaczyszyn, Piotr Ponikowski

Abstract


No abstract

Keywords


Heart Failure; Iron therapy

Full Text:

Jankowska-625

References


Jankowska EA, Von Haehling S, Anker SD, MacDougall IC, Ponikowski P. Iron deficiency and heart failure: Diagnostic dilemmas and therapeutic perspectives. Eur Heart J 2013;34:816–826.

Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, Banasiak W, von Haehling S, Macdougall IC, Weiss G, McMurray JJ V, Anker SD, Gheorghiade M, Ponikowski P. Iron status in patients with chronic heart failure. Eur Heart J 2013;34:827–834.

Jankowska EA, Kasztura M, Sokolski M, Bronisz M, Nawrocka S, Ole kowska-Florek W, Zymli ski R, Biegus J, Siwo owski P, Banasiak W, Anker SD, Filippatos G, Cleland JGF, Ponikowski P. Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. Eur Heart J 2014;35:2468–2476.

Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan B, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P. Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. N Engl J Med 2009;361:2436–2448

Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh T, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur

Heart J 2015;36:657–668.

van Veldhuisen DJ, Ponikowski P, van der Meer P, Metra M, Böhm M, Doletsky A,

Voors AA, Macdougall IC, Anker SD, Roubert B, Zakin L, Cohen-Solal A; EFFECT-HF Investigators. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency. Circulation. 2017;13 :1374-1383.

Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986–1995.

Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-

restricted erythropoiesis. Blood 2010;116:4754–4761.

Hughes CM, Woodside J V, McGartland C, Roberts MJ, Nicholls DP, McKeown PP.

Nutritional intake and oxidative stress in chronic heart failure. Nutr Metab Cardiovasc

Dis Elsevier; 2012;22:376–382.

Lourenço BH, Vieira LP, Macedo A, Nakasato M, Marucci M de FN, Bocchi EA.

Nutritional status and adequacy of energy and nutrient intakes among heart failure

patients. Arq Bras Cardiol 2009;93:541–548.

Hallberg L, Hulthén L. Prediction of dietary iron absorption: An algorithm for calculating

absorption and bioavailability of dietary iron. Am J Clin Nutr 2000;71:1147–1160.

González-Costello J, Comín-Colet J. Iron deficiency and anaemia in heart failure:

Understanding the FAIR-HF trial [Internet]. Eur. J. Heart Fail. 2010. p. 1159–1162.

Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr

;26:323–342.

Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M,

Sawadogo M, Kahn A, Vaulont S. Severe iron deficiency anemia in transgenic mice

expressing liver hepcidin. Proc Natl Acad Sci U S A 2002;99:4596–4601.

Silvestri L. Inhibiting the hepcidin inhibitor for treatment of iron overload. Blood. 2013.

p. 1068–1069.

Moreno Chulilla JA, Romero Colás MS, Gutiérrez Martín M. Classification of anemia for

gastroenterologists. World J Gastroenterol 2009;15:4627–4637.

Goddard AF, James MW, McIntyre AS, Scott BB, British Society of Gastroenterology.

Guidelines for the management of iron deficiency anaemia. Gut 2 11;60:1309–1316.

Gale E, Torrance J, Bothwell T. The quantitative estimation of total iron stores in human bone

marrow. J Clin Invest American Society for Clinical Investigation; 1963;42:1076–1082.19.

Pasricha S-RS, Flecknoe-Brown SC, Allen KJ, Gibson PR, McMahon LP, Olynyk JK, Roger SD, Savoia HF, Tampi R, Thomson AR, Wood EM, Robinson KL. Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust 2010;193:525–532.

Wish JB. Assessing Iron Status: Beyond Serum Ferritin and Transferrin Saturation. Clin

J Am Soc Nephrol American Society of Nephrology; 2006;1:S4–S8.

Ali MA, Luxton AW, Walker WH. Serum ferritin concentration and bone marrow iron stores: a prospective study. Can Med Assoc J Canadian Medical Association;

;118:945–946.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-

Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members; Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur J Heart Fail. 2016;18:891-975.

Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, Tang WHW, LaRue SJ, Redfield MM, Semigran MJ, Givertz MM, Van Buren P, Whellan D, Anstrom KJ, Shah MR, Desvigne-Nickens P, Butler J, Braunwald E; NHLBI Heart Failure Clinical Research Network. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial. JAMA. 2017;317:1958-1966.

Koulaouzidis A, Said E, Cottier R, Saeed AA. Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. J Gastrointestin Liver Dis

;18:345–352.

Okonko DO, Mandal AKJ, Missouris CG, Poole-Wilson PA. Disordered iron homeostasis

in chronic heart failure: Prevalence, predictors, and relation to anemia, exercise

capacity, and survival. J Am Coll Cardiol Elsevier Inc.; 2011;58:1241–1251.

Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJ V, Anker SD, Ponikowski P. Iron deficiency: An ominous sign in patients with systolic chronic heart

failure. Eur Heart J 2010;31:1872–1880.

Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, Lok DJ,

Rosentryt P, Torrens A, Polonski L, Van Veldhuisen DJ, Van Der Meer P, Jankowska EA. Iron deficiency in chronic heart failure: An international pooled analysis. Am Heart J Mosby, Inc.; 2013;165:575–582.e3.29.

Kasner M, Aleksandrov AS, Westermann D, Lassner D, Gross M, Von Haehling S, Anker SD, Schultheiss HP, Tschöpe C. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction. Int J Cardiol Elsevier Ireland Ltd; 2013;168:4652–4657.

Yeo TJ, Yeo PSD, Ching-Chiew Wong R, Ong HY, Leong KTG, Jaufeerally F, Sim D, Santhanakrishnan R, Lim SL, M.Y. Chan M, Chai P, Low AF, Ling LH, Ng TP, Richards AM, Lam CSP. Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis. Eur J Heart Fail 2014;16:1125–1132.

Ebner N, Jankowska EA, Ponikowski P, Lainscak M, Elsner S, Sliziuk V, Steinbeck L, Kube J, Bekfani T, Scherbakov N, Valentova M, Sandek A, Doehner W, Springer J, Anker SD, Von Haehling S. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure. Int J Cardiol Elsevier Ireland Ltd; 2016;205:6–12.

Núñez J, Domínguez E, Ramón JM, Núñez E, Sanchis J, Santas E, Heredia R, González J, Miñana G, López L, Chorro FJ, Palau P. Iron deficiency and functional capacity in patients with advanced heart failure with preserved ejection fraction. Int J Cardiol Elsevier Ireland Ltd; 2016;207:365–367.

Martens P, Nijst P, Verbrugge FH, Smeets K, Dupont M, Mullens W. Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction. Acta Cardiol. 2018;73: 115-123.

Cohen-Solal A, Damy T, Terbah M, Kerebel S, Baguet JP, Hanon O, Zannad F, Laperche T, Leclercq C, Concas V, Duvilli L, Darn B, Anker S, Mebazaa A. High prevalence of iron deficiency in patients with acute decompensated heart failure. Eur J Heart Fail 2014;16:984–991.

Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Von Haehling S, Doehner W, Banasiak W, Polonski L, Filippatos G, Anker SD, Ponikowski P. Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J Card Fail Elsevier Inc; 2011;17:899–906.

Comín-Colet J, Enjuanes C, González G, Torrens A, Cladellas M, Meroño O, Ribas N, Ruiz S, Gómez M, Verdú JM, Bruguera J. Iron deficiency is a key determinant of health- related quality of life in patients with chronic heart failure regardless of anaemia status. Eur J Heart Fail 2013;15:1164–1172.

Enjuanes C, Klip IT, Bruguera J, Cladellas M, Ponikowski P, Banasiak W, van Veldhuisen DJ, van der Meer P, Jankowska EA, Comín-Colet J. Iron deficiency and health-related quality of life in chronic heart failure: Results from a multicenter European study. Int J Cardiol Elsevier Ireland Ltd; 2014;174:268–275.

Parikh A, Natarajan S, Lipsitz SR, Katz SD. Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: Prevalence and associations with anemia and inflammation. Circ Hear Fail 2011;4:599–606.

Rangel I, Gonçalves A, de Sousa C, Leite S, Campelo M, Martins E, Amorim S, Moura B, Silva Cardoso J, Maciel MJ. Iron Deficiency Status Irrespective of Anemia: A Predictor of Unfavorable Outcome in Chronic Heart Failure Patients. Cardiology 2014;128:320–326.

Aung N, Ling HZ, Cheng AS, Aggarwal S, Flint J, Mendonca M, Rashid M, Kang S, Weissert S, Coats CJ, Richards T, Thomas M, Woldman S, Okonko DO. Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure. Int J Cardiol Elsevier; 2013;168:1997–2002.

HeathCW,StraussMB,CastleWB.Quantitativeaspectsofriondeficiencyinhypochromic anemia: (The Parenteral Administration of Iron). J Clin Invest 1932;11:1293–1312.

Goetsch AT, Moore CV, Minnich V. Observations on the effect of massive doses of iron given intravenously to patients with hypochromic anemia. J Lab Clin Med 1946;31:466.

Silvestri L. Inhibiting the hepcidin inhibitor for treatment of iron overload [Internet].

Blood. 2013. p. 1068–1069.

Evans RW, Rafique R, Zarea A, Rapisarda C, Cammack R, Evans PJ, Porter JB,

Hider RC. Nature of non-transferrin-bound iron: studies on iron citrate complexes and

thalassemic sera. JBIC J Biol Inorg Chem Springer-Verlag; 2007;13:57–74.

Macdougall IC. Evolution of iv iron compounds over the last century. J Ren Care

;35 Suppl 2:8–13.

Ganzoni AM. [Intravenous iron-dextran: therapeutic and experimental possibilities].

Schweiz Med Wochenschr 1970;100:301–303.

Filippatos G, Farmakis D, Colet JC, Dickstein K, Lüscher TF, Willenheimer R, Parissis

J, Gaudesius G, Mori C, Rothe BVE, Greenlaw N, Ford I, Ponikowski P, Anker SD. Intravenous ferric carboxymaltose in iron-Deficient chronic heart failure patients with and without anaemia: A subanalysis of the FAIR-HF trial. Eur J Heart Fail 2013;15:1267–1276.

Bolger AP, Bartlett FR, Penston HS, O’Leary J, Pollock N, Kaprielian R, Chapman CM. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol 2006;48:1225–1227.

Toblli JE, Lombraña A, Duarte P, Di Gennaro F. Intravenous Iron Reduces NT-Pro- Brain Natriuretic Peptide in Anemic Patients With Chronic Heart Failure and Renal Insufficiency. J Am Coll Cardiol 2007;50:1657–1665

Okonko DO, Grzeslo A, Witkowski T, Mandal AKJ, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency. J Am Coll Cardiol 2008;51:103–112.

Usmanov RI, Zueva EB, Silverberg DS, Shaked M. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. J Ne hrol 2008;21:236–242.

Gaber R, Kotb NA, Ghazy M, Nagy HM, Salama M, Elhendy A. Tissue Doppler and Strain Rate Imaging Detect Improvement of Myocardial Function in Iron Deficient Patients with Congestive Heart Failure after Iron Replacement Therapy. Echocardiography 2012;29:13–18.

Jankowska EA, Tkaczyszyn M, Suchocki T, Drozd M, von Haehling S, Doehner W, Banasiak W, Filippatos G, Anker SD, Ponikowski P. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. Eur J Heart Fail 2016;18:786-95.

Anker SD, Kirwan BA, van Veldhuisen DJ, Filippatos G, Comin-Colet J, Ruschitzka F, Lüscher TF, Arutyunov GP, Motro M, Mori C, Roubert B, Pocock SJ, Ponikowski P. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficien heart failure patients: an individual patient data meta-analysis.Eur J Heart Fail. 2018;20: 125-133




DOI: https://doi.org/10.17987/icfj.v18i0.625

Copyright (c) 2019 Ewa Jankowska, Marcin Drozd, Michał Tkaczyszyn, Piotr Ponikowski

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.